Literature DB >> 24786464

Is nanotechnology a boon for oral drug delivery?

Udita Agrawal1, Rajeev Sharma1, Madhu Gupta1, Suresh P Vyas2.   

Abstract

The oral route for drug delivery is regarded as the optimal route for achieving therapeutic benefits owing to increased patient compliance. Despite phenomenal advances in injectable, transdermal, nasal and other routes of administration, the reality is that oral drug delivery remains well ahead of the pack as the preferred delivery route. Nanocarriers can overcome the major challenges associated with this route of administration: mainly poor solubility, stability and biocompatibility of drugs. This review focuses on the potential of various polymeric drug delivery systems in oral administration, their pharmacokinetics, in vitro and in vivo models, toxicity and regulatory aspects.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24786464     DOI: 10.1016/j.drudis.2014.04.011

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  28 in total

1.  Single small molecule-assembled nanoparticles mediate efficient oral drug delivery.

Authors:  Xin Yang; Chao Ma; Zeming Chen; Jun Liu; Fuyao Liu; Rongbin Xie; Haitian Zhao; Gang Deng; Ann T Chen; Ningbo Gong; Lei Yao; Pengjian Zuo; Kangkang Zhi; Jiacheng Wang; Xiaobin Gao; Jing Wang; Louzhen Fan; Jiangbing Zhou
Journal:  Nano Res       Date:  2019-07-24       Impact factor: 10.269

2.  Enhanced oral bioavailability and antitumor therapeutic efficacy of sorafenib administered in core-shell protein nanoparticle.

Authors:  Lekshmi Gopakumar; Maya Sreeranganathan; Shalin Chappan; Sneha James; Genekehal Siddaramana Gowd; Maneesh Manohar; Arya Sukumaran; Ayalur Kodakara Kochugovindan Unni; Shantikumar Vasudevan Nair; Manzoor Koyakutty
Journal:  Drug Deliv Transl Res       Date:  2022-06-09       Impact factor: 5.671

Review 3.  Planar bioadhesive microdevices: a new technology for oral drug delivery.

Authors:  Cade B Fox; Hariharasudhan D Chirra; Tejal A Desai
Journal:  Curr Pharm Biotechnol       Date:  2014       Impact factor: 2.837

Review 4.  Micro/nanofabricated platforms for oral drug delivery.

Authors:  Cade B Fox; Jean Kim; Long V Le; Cameron L Nemeth; Hariharasudhan D Chirra; Tejal A Desai
Journal:  J Control Release       Date:  2015-08-02       Impact factor: 9.776

Review 5.  NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?

Authors:  Sanghamitra Sahoo; Daniel N Meijles; Patrick J Pagano
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

6.  Preparation and evaluation of Vinpocetine self-emulsifying pH gradient release pellets.

Authors:  Mengqi Liu; Shiming Zhang; Shuxia Cui; Fen Chen; Lianqun Jia; Shu Wang; Xiumei Gai; Pingfei Li; Feifei Yang; Weisan Pan; Xinggang Yang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 7.  Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs.

Authors:  Mayank Sharma; Rajesh Sharma; Dinesh Kumar Jain
Journal:  Scientifica (Cairo)       Date:  2016-04-30

8.  Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.

Authors:  Deqing Sun; Aiying Xue; Bin Zhang; Xia Xue; Jie Zhang; Wenjie Liu
Journal:  Drug Des Devel Ther       Date:  2016-06-21       Impact factor: 4.162

Review 9.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges.

Authors:  Dinh Ha; Ningning Yang; Venkatareddy Nadithe
Journal:  Acta Pharm Sin B       Date:  2016-03-08       Impact factor: 11.413

Review 10.  Preparation and Antimicrobial Activity of Chitosan and Its Derivatives: A Concise Review.

Authors:  Luminita Georgeta Confederat; Cristina Gabriela Tuchilus; Maria Dragan; Mousa Sha'at; Oana Maria Dragostin
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.